Institute of Molecular Genetics IGM-CNR "Luigi Luca Cavalli-Sforza", Via Abbiategrasso 207, 27100, Pavia, Italy.
Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, 27100, Pavia, Italy.
Antiviral Res. 2019 Nov;171:104593. doi: 10.1016/j.antiviral.2019.104593. Epub 2019 Aug 27.
The influenza A virus (IAV) NS1 protein is one of the major regulators of pathogenicity, being able to suppress innate immune response and host protein synthesis. In this study we identified the human micro RNA hsa-miR-1307-3p as a novel potent suppressor of NS1 expression and influenza virus replication. Transcriptomic analysis indicates that hsa-miR-1307-3p also negatively regulates apoptosis and promotes cell proliferation. In addition, we identified a novel mutation in the NS1 gene of A(H1N1)pdm09 strains circulating in Italy in the 2010-11 season, which enabled the virus to escape the hsa-miR-1307-3p inhibition, conferring replicative advantage to the virus in human cells. To the best of our knowledge, this is the first validation of suppression of IAV H1N1 NS1 by a human micro RNA and the first example of an escape mutation from micro RNA-mediated antiviral response for the A(H1N1)pdm09 virus.
甲型流感病毒(IAV)的 NS1 蛋白是主要的致病性调节因子之一,能够抑制先天免疫反应和宿主蛋白合成。在这项研究中,我们鉴定出人类 microRNA hsa-miR-1307-3p 是 NS1 表达和流感病毒复制的新型有效抑制剂。转录组分析表明,hsa-miR-1307-3p 还能负调控细胞凋亡并促进细胞增殖。此外,我们还鉴定出在 2010-11 季节意大利流行的 A(H1N1)pdm09 株系的 NS1 基因中的一个新突变,该突变使病毒能够逃避 hsa-miR-1307-3p 的抑制,从而赋予病毒在人类细胞中的复制优势。据我们所知,这是首次验证人类 microRNA 对甲型流感病毒 H1N1 NS1 的抑制作用,也是 A(H1N1)pdm09 病毒逃避 microRNA 介导的抗病毒反应的首例实例。